BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12759537)

  • 21. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
    Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
    Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
    Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
    Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
    Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
    Kim JP; Oh ST; Hwang TS; Chi JG
    J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The salivary tip of the p53 mutagenesis iceberg: novel insights.
    Ben-Izhak O; Laster Z; Akrish S; Muska E; Gan S; Nagler RM
    Cancer Biomark; 2009; 5(1):23-31. PubMed ID: 19242059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer.
    Shpitz B; Bomstein Y; Sternberg A; Klein E; Liverant S; Groisman G; Bernheim J
    J Surg Oncol; 2000 Dec; 75(4):252-7. PubMed ID: 11135266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables.
    Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R
    Dis Colon Rectum; 2000 Sep; 43(9):1227-36. PubMed ID: 11005488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors.
    Manjunatha BS; Kumar GS; Raghunath V
    Med Oral Patol Oral Cir Bucal; 2011 Jul; 16(4):e503-7. PubMed ID: 21196881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
    Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
    J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of apoptosis-related markers in malignant epithelial tumours of the lacrimal gland and their relation to clinical outcome.
    Strianese D; Baldi G; Staibano S; Baldi A; De Rosa G; Tranfa F; Bonavolontà G
    Br J Ophthalmol; 2007 Sep; 91(9):1239-43. PubMed ID: 17431014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleomorphic adenoma of oral minor salivary glands: An investigation of its neoplastic potential based on apoptosis, mucosecretory activity and cellular proliferation.
    Ferreira JC; Morais MO; Elias MR; Batista AC; Leles CR; Mendonça EF
    Arch Oral Biol; 2014 Jun; 59(6):578-85. PubMed ID: 24681706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.
    Rolland P; Spendlove I; Madjd Z; Rakha EA; Patel P; Ellis IO; Durrant L
    Int J Cancer; 2007 Mar; 120(6):1311-7. PubMed ID: 17187363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.
    Sjögren S; Inganäs M; Lindgren A; Holmberg L; Bergh J
    J Clin Oncol; 1998 Feb; 16(2):462-9. PubMed ID: 9469329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.